These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19661994)

  • 41. Reconstituted microsomal lipid peroxidation: ADP-Fe3+-dependent peroxidation of phospholipid vesicles containing NADPH-cytochrome P450 reductase and cytochrome P450.
    Morehouse LA; Aust SD
    Free Radic Biol Med; 1988; 4(5):269-77. PubMed ID: 3129344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of cytochrome P450 lysine residues in the interaction between cytochrome P450IA1 and NADPH-cytochrome P450 reductase.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1992 Apr; 294(1):83-90. PubMed ID: 1550361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase.
    Kondo S; Sakaki T; Ohkawa H; Inouye K
    Biochem Biophys Res Commun; 1999 Apr; 257(2):273-8. PubMed ID: 10198202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation.
    Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI
    Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidation of indole by cytochrome P450 enzymes.
    Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
    Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular cloning, bacterial expression and functional characterisation of cytochrome P450 monooxygenase, CYP97C27, and NADPH-cytochrome P450 reductase, CPR I, from Croton stellatopilosus Ohba.
    Sintupachee S; Ngamrojanavanich N; Sitthithaworn W; De-Eknamkul W
    Plant Sci; 2014 Dec; 229():131-141. PubMed ID: 25443840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.
    Dutton DR; Parkinson A
    Arch Biochem Biophys; 1989 Feb; 268(2):617-29. PubMed ID: 2536534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rotation of cytochrome P-450. Complex formation of cytochrome P-450 with NADPH-cytochrome P-450 reductase in liposomes demonstrated by combining protein rotation with antibody-induced cross-linking.
    Gut J; Richter C; Cherry RJ; Winterhalter KH; Kawato S
    J Biol Chem; 1983 Jul; 258(14):8588-94. PubMed ID: 6408090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4.
    Lee CA; Kadwell SH; Kost TA; Serabjit-Singh CJ
    Arch Biochem Biophys; 1995 May; 319(1):157-67. PubMed ID: 7771780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of a cytochrome P450 system in microsomal debromination of alpha-(bromisovaleryl)urea.
    Oka K; Kitamura S; Tatsumi K
    J Pharm Pharmacol; 1996 Sep; 48(9):930-2. PubMed ID: 8910855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
    Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
    Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
    Sheweita SA
    Toxicology; 2003 Sep; 191(2-3):133-42. PubMed ID: 12965116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase.
    Vermilion JL; Coon MJ
    J Biol Chem; 1978 Dec; 253(24):8812-9. PubMed ID: 31362
    [No Abstract]   [Full Text] [Related]  

  • 56. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M; Frei E; Wiessler M; Schmeiser HH
    Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytochromes P450 2B1 and P450 2B2 demethylate N-nitrosodimethylamine and N-nitrosomethylaniline in vitro.
    Stiborová M; Hansíková H; Frei E
    Gen Physiol Biophys; 1996 Jun; 15(3):211-23. PubMed ID: 9076504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of banol and paraoxon on the NADPH-cytochrome c reductase activity and cytochrome P-450 content in rats.
    Neskovic NK; Vitorovic SL
    Bull Environ Contam Toxicol; 1977 Oct; 18(4):472-7. PubMed ID: 411532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
    Kousba A; Soll R; Yee S; Martin M
    Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.